PRIMECAP PORTFOLIO
VANGUARD VARIABLE INSURANCE FUNDS
Fund classification
Classified from what the fund holds · as of 2026 Q2
PRIMECAP PORTFOLIO is an actively managed U.S. equity fund. 16% of PRIMECAP PORTFOLIO’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 89% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2026 Q2
Vanguard Variable Insurance Funds Capital Growth Portfolio (the Fund) seeks to provide long-term capital appreciation.
The fund actively selects large- and mid-capitalization stocks expected to deliver above-average earnings growth that the market has not yet priced in. Because returns depend on the manager's ability to identify undervalued growth opportunities, performance may diverge materially from broad market returns.
| Share class | Expense ratio |
|---|---|
| C000012153 | 0.34% |
Portfolio turnover 15.00% · as of 2026 Q2
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 97.09% |
| Cash & short-term | 3.11% |
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Information Technology | 40.7% |
| Health Care | 15.9% |
| Industrials | 10.7% |
| Consumer Discretionary | 7.5% |
| 8 smaller | 25.2% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| MU | Micron Technology IncMU | 15.26% | $1,154.29 | $474.18M | 410.8K |
| LLY | Eli Lilly & CoLLY | 6.62% | $1,199.43 | $205.79M | 171.6K |
| INTC | Intel CorpINTC | 6.38% | $139.63 | $198.19M | 1.4M |
| KLAC | KLA CorpKLAC | 4.37% | $301.71 | $135.77M | 450.0K |
| GOOGL | Alphabet IncGOOGL | 3.48% | $357.37 | $108.07M | 302.4K |
| — | Vanguard Cmt Funds-Vanguard Market Liquidity Fund | 3.11% | — | $96.68M | — |
| NVDA | NVIDIA CorpNVDA | 2.31% | $200.09 | $71.84M | 359.1K |
| — | AstraZeneca PLC | 2.28% | $189.62 | $70.81M | 373.4K |
| TXN | Texas Instruments IncTXN | 2.06% | $298.07 | $63.97M | 214.6K |
| AMZN | Amazon.com IncAMZN | 2.01% | $238.34 | $62.41M | 261.9K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 47.88% of net assets, top 25 69.16%, across 131 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free